Research output per year
Research output per year
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Aberrations in circulating ceramide levels are associated with poor clinical outcomes across localised and metastatic prostate cancer
Lin, H. M., Huynh, K., Kohli, M., Tan, W., Azad, A. A., Yeung, N., Mahon, K. L., Mak, B., Sutherland, P. D., Shepherd, A., Mellett, N., Docanto, M., Giles, C., Centenera, M. M., Butler, L. M., Meikle, P. J. & Horvath, L. G., Sep 2021, In: Prostate Cancer and Prostatic Diseases. 24, 3, p. 860-870 11 p.Research output: Contribution to journal › Article › peer-review
3 Citations (Scopus) -
ELOVL5 is a critical and targetable fatty acid elongase in prostate cancer
Centenera, M. M., Scott, J. S., Machiels, J., Nassar, Z. D., Miller, D. C., Zinonos, I., Dehairs, J., Burvenich, I. J. G., Zadra, G., Chetta, P. M., Bango, C., Evergren, E., Ryan, N. K., Gillis, J. L., Mah, C. Y., Tieu, T., Hanson, A. R., Carelli, R., Bloch, K., Panagopoulos, V. & 13 others, , Apr 2021, In: Cancer Research. 81, 7, p. 1704-1718 15 p.Research output: Contribution to journal › Article › peer-review
7 Citations (Scopus) -
Lipidomic profiling of clinical prostate cancer reveals targetable alterations in membrane lipid composition
Butler, L., Mah, C. Y., Machiels, J., Vincent, A., Irani, S., Mutuku, S. M., Spotbeen, X., Lynn, D., Tilley, W. D., Horvath, L. G., Centenera, M., Swinnen, J. V. & Trim, P., 6 Aug 2021, In: Cancer Research.Research output: Contribution to journal › Article › peer-review
Open Access -
Synthesis and fluorine-18 radiolabeling of a phospholipid as a PET imaging agent for prostate cancer
Kwan, K. H., Burvenich, I. J. G., Centenera, M. M., Goh, Y. W., Rigopoulos, A., Dehairs, J., Swinnen, J. V., Raj, G. V., Hoy, A. J., Butler, L. M., Scott, A. M., White, J. M. & Ackermann, U., Feb 2021, In: Nuclear Medicine and Biology. 93, p. 37-45 9 p.Research output: Contribution to journal › Article › peer-review
-
Fatty acid oxidation is an adaptive survival pathway induced in prostate tumors by HSP90 inhibition
Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., Nguyen, E. V., Nagarajan, S. R., Moldovan, M., Lynn, D. J., Daly, R. J., Hoy, A. J. & Butler, L. M., 1 Oct 2020, In: Molecular Cancer Research. 18, 10, p. 1500-1511 12 p.Research output: Contribution to journal › Article › peer-review
3 Citations (Scopus)